Skip to Content

88 MYLAN (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)

Pill with imprint 88 MYLAN is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 88 MYLAN

Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN
Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN Front
Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN Back
Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN

Carbidopa and Levodopa Extended Release

Imprint:
88 MYLAN
Strength:
25 mg / 100 mg
Color:
Purple
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
FD&C Blue No. 2
FD&C Red No. 40
hydroxypropyl cellulose
hypromelloses
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0978 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide